🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Vegecap(s) Serving Size
30 Servings
Other Combinations Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

PQQ
20 mg
📊 Market median: 20.0mg (9 products) 📚 5 studies — no high-quality reviews
This product: 20mg
60 mg
📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)
This product: 60mg UL 1200mg
Oxystorm
100 mg
400 mg
📊 Market median: 500.0mg (143 products)
This product: 400mg
Epicatechin
60 mg

Other Ingredients

Gamma Cyclodextrin Hypromellose non-GMO Vegetable Magnesium Stearate Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (87% of products) Nutrient (13% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: Adults: Take two (2) vegecaps daily as a dietary supplement or as recommended by your healthcare professional.

⚠️ Warnings & Precautions

Caution: Before using any dietary supplement, pregnant or lactating women should consult with a physician or health professional.

Keep out of reach of children.

Do not use if safety seal is broken or missing.

To report a serious adverse event or to obtain product information contact 1-866-319-6299.

🧪 Formulation Notes

Free Of: Milk, egg, fish, shellfish, tree nuts, wheat, peanuts and soybeans. Non-GMO, gluten free, soy free

Manufactured in a cGMP Certified U.S.A. Facility.

Cellular optimized Optimal cardiovascular and mitochondria function Studied

Non GMO Soy free

cGMP

Additional Information

Keep bottle tightly closed. Store between 15 degrees - 30 degrees C (59 degrees - 86 degrees F).

Product Details

UPC / SKU 8 19193 02086 9
DSLD Entry Date 2022-07-21
Product Type Other Combinations
Form Capsule
DSLD ID 268167
Data Updated 2026-04-11

Research Evidence

202 Research Sources
55 Avg Quality Score
86 Meta Analysis
62 Systematic Review
28 Rct
17 Clinical Trial
4 Regulatory Source
2 Other
1 Narrative Review
1 Openfda Safety
A Coenzyme Q10 for heart failure
Meta Analysis The Cochrane database of systematic reviews 2021
A Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2011
A Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis
Meta Analysis BMJ open 2021
A Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
Meta Analysis Irish journal of medical science 2022
B Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2008
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2016
B Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Meta Analysis Reproductive sciences (Thousand Oaks, Calif.) 2023
B Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials
Meta Analysis International journal of molecular sciences 2020
B Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Meta Analysis Journal of nutritional science 2025
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Coq10 →

Compare Similar Products

View all Coq10 products →